Litcius/Paper detail

Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: A randomized clinical trial

Weiwei Xiao, Gong Chen, Yuanhong Gao, Junzhong Lin, Xiaojun Wu, Huilong Luo, Zhenhai Lu, Qiaoxuan Wang, Rui Sun, Peiqiang Cai, Chong-Mei Zhu, Min Liu, Jibin Li, Yi‐Rui Wang, Ying Jin, Rui Wang, Haitao Luo, Cailing Li, Zhizhong Pan, Rui‐Hua Xu

2024Cancer Cell80 citationsDOI

Topics & Concepts

MedicineConfidence intervalInternal medicineColorectal cancerRandomized controlled trialClinical endpointChemoradiotherapyImmunohistochemistryAntibodyGastroenterologyOncologyCancerImmunologyColorectal Cancer Surgical TreatmentsGenetic factors in colorectal cancerColorectal and Anal Carcinomas
Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: A randomized clinical trial | Litcius